Background and aim: Chronic periodontitis has been defined as an infectious disease resulting in inflammation within the dental supporting tissue, progressive attachment loss and bone resorption. Nowadays, with increasing microbial resistance, bacterial therapy is an alternative to prevent inflammatory diseases of the oral cavity, which regulates oral microbiota and eliminating pathogenic bacteria. The aim of this study was to identify oral Lactobacillus species and in patients with periodontitis and healthy individuals.

Results: Out Of 354 examined isolates, 254 isolates were positive for Lactobacillus based on culture and PCR results. From obtained strain cutting patterns analysis of the oral lactobacillus community, were aggregated into ten different species. L.paracasei, L.fermentumin patient and L.casei, L.plantarum were the most predominant species in control groups. 

Conclusion: The frequency of Lactobacillus in patients with periodontitis was significantly reduced comparing to the control group, especially in gingival plaque samples. The difference in the frequency of isolated lactobacillus in the total sample of patients was 8% less than control subjects. There is increasing evidence that the use of existing lactobacillus strains can prevent chronic periodontitis. These probiotic candidates can be selected for the purpose of bacteriotherapy, dairy manufacture and pharmaceutical use.